Sample result
GLP-1, a diabetes hormone
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
- Search
- Protein → Patent proteins · Automatic (Smith-Waterman)
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 5,000 sequences, 3,061 publications, 1,851 families
Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.
Patents
3,061 publications in 1,851 families match these filters.
-
US 9546205-B22017-01-17
Peptide analogues of glucagon and GLP1
IMPERIAL INNOVATIONS LIMITED
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 3116878-A12017-01-18
FXR AGONISTS AND METHODS FOR MAKING AND USING
SALK INST FOR BIOLOGICAL STUDIES
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
JP 2017502024-A2017-01-19
MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF
THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH, THE SCRIPPS RESEARCH INSTITUTE
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 9616108-B22017-04-11
Methods and compositions for treating hypoglycemic disorders
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA and CHILDREN'S HOSPITAL OF PHILADELPHIA
Query Match 96.3%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- US 9616108-B22017-04-11
- US 9821031-B22017-11-21
- US 10188702-B22019-01-29
- US 10987407-B22021-04-27
-
JP 2017510572-A2017-04-13
FXR AGONISTS AND METHODS FOR MAKING AND USING
SALK INSTITUTE FOR BIOLOGICAL STUDIES
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2017510572-A2017-04-13
- US 10077268-B22018-09-18
-
JP 2017511304-A2017-04-20
ANALOGS OF FEXARAMINE AND METHODS OF MAKING AND USING
SALK INSTITUTE FOR BIOLOGICAL STUDIES
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
WO 2017074714-A12017-05-04
GLUCAGON RECEPTOR AGONISTS
LILLY CO ELI
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2017074714-A12017-05-04
- WO 2017074715-A12017-05-04
-
US 9682127-B22017-06-20
Osmotic delivery device comprising an insulinotropic peptide and uses thereof
INTARCIA THERAPEUTICS, INC.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 9688736-B22017-06-27
Compound for treatment of severe hypoglycemia
Eli Lilly and Company
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 9695225-B22017-07-04
Peptide compound for treatment of severe hypoglycemia
Eli Lilly and Company
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 9700543-B22017-07-11
GLP-1 receptor stabilizers and modulators
Celgene International II SARL
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 3202779-A22017-08-09
LONG-ACTING HGH POLYPEPTIDES AND USES THEREOF
OPKO BIOLOGICS LTD
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
JP 2017524680-A2017-08-31
PHARMACEUTICAL COMPOSTIONS
GlaxoSmithKline LLC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 9764004-B22017-09-19
Glucagon receptor agonists
Eli Lilly and Company
Query Match 96.3%Identity 100.0%Family of 5
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- US 9764004-B22017-09-19
- US 9884093-B22018-02-06
- JP 2018504376-A2018-02-15
- JP 2018508464-A2018-03-29
- JP 2018135346-A2018-08-30
-
WO 2017178829-A12017-10-19
PEPTIDE ANALOGUES
IMP INNOVATIONS LTD
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 3240564-A22017-11-08
METHODS OF PRODUCING LONG ACTING CTP-MODIFIED POLYPEPTIDES
OPKO BIOLOGICS LTD
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 3240564-A22017-11-08
- EP 4212546-A12023-07-19
-
KR 1020170123658-A2017-11-08
TREATING LATENT AUTOIMMUNE DIABETES OF ADULTS WITH FARNESOID X RECEPTOR AGONISTS TO ACTIVATE INTESTINAL RECEPTORS
THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
KR 1020170137106-A2017-12-12
METHOD AND ELECTRONIC SYSTEM FOR PREDICTING AT LEAST ONE FITNESS VALUE OF A PROTEIN, RELATED COMPUTER PROGRAM PRODUCT
PEACCEL
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020170137106-A2017-12-12
- JP 2018517219-A2018-06-28
-
US 9856306-B22018-01-02
Peptide pharmaceuticals for insulin resistance
SPITFIRE PHARMA, INC.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 3267991-A12018-01-17
TREATING LATENT AUTOIMMUNE DIABETES OF ADULTS WITH FARNESOID X RECEPTOR AGONISTS TO ACTIVATE INTESTINAL RECEPTORS
SALK INST FOR BIOLOGICAL STUDI
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 3270946-A22018-01-24
MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF
THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 3270946-A22018-01-24
- EP 3310376-A12018-04-25
-
US 9884092-B22018-02-06
Methods for treating diabetes and reducing body weight
Amylin Pharmaceuticals, LLC and AstraZeneca Pharmaceuticals LP
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 9889085-B12018-02-13
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
INTARCIA THERAPEUTICS, INC.
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 9889085-B12018-02-13
- US 10583080-B22020-03-10
-
WO 2018050902-A22018-03-22
MULTIMERS, TETRAMERS & OCTAMERS
QUADRUCEPT BIO LTD
Query Match 96.3%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 || |||||||||||||||||||||||||||| Hit 1 HAPGTFTSDVSSYLEGQAAKEFIAWLVKGRG 3130 of 31 identical, no gaps.
-
US 9944687-B22018-04-17
Compounds and their effects on feeding behaviour
Imperial Innovations Limited
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
JP 2018510866-A2018-04-19
TREATING LATENT AUTOIMMUNE DIABETES OF ADULTS WITH FARNESOID X RECEPTOR AGONISTS TO ACTIVATE INTESTINAL RECEPTORS
Salk Institute for Biological Studies
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 9950038-B22018-04-24
Methods and compositions for inhibiting delayed graft function
THE TRUSTEES OF THE UNIVERSIY OF PENNSYLVANIA
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
WO 2018075901-A12018-04-26
METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM
PEPTRON INC
Query Match 96.3%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2018075901-A12018-04-26
- JP 2023065401-A2023-05-12
- EP 4635569-A22025-10-22
-
US 9999689-B22018-06-19
Imaging beta cell mass
The General Hospital Corporation
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 10005817-B22018-06-26
Peptide pharmaceuticals
EUMEDERIS PHARMACEUTICALS, INC.
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10005817-B22018-06-26
- US 10010617-B22018-07-03
-
US 10010589-B22018-07-03
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH and THE SCRIPPS RESEARCH INSTITUTE
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10010589-B22018-07-03
- US 10039809-B22018-08-07
-
EP 3345593-A12018-07-11
PHARMACEUTICAL COMPOSITION COMPRISING DESPRO36EXENDIN-4(1-39)-LYS6-NH2 AND METHIONINE
SANOFI AVENTIS DEUTSCHLAND
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 10028910-B22018-07-24
Pharmaceutical composition comprising a GLP-1-agonist and methionine
SANOFI-AVENTIS DEUTSCHLAND GMBH
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
KR 1020180084680-A2018-07-25
Recombinant vector for expressing target protein
POSTECH ACADEMY-INDUSTRY FOUNDATION
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
JP 2018522835-A2018-08-16
Prodrugs comprising an GLP-1/Glucagon dual agonist linker hyaluronic acid conjugate
SANOFI
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2018522835-A2018-08-16
- US 10806797-B22020-10-20
-
EP 3368693-A22018-09-05
OXYNTOMODULIN ANALOGS AND METHODS OF MAKING AND USING SAME
THE RESEARCH FOUNDATION FOR THE STATE UNIV OF NEW YORK UNIV AT BUFFALO
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
KR 1020180124816-A2018-11-21
Pharmaceutical composition for treating muscle atrophy comprising glucagon like-peptide-1, GLP-1 derived peptide, or GLP-1 degradation inhibitor
ImmunoForge Co.,Ltd
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 7 to 36. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3630 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020180124816-A2018-11-21
- KR 1020190123713-A2019-11-01
-
US 10137171-B22018-11-27
Methods of treatment using a pentapeptide derived from the C-Terminus of Glucagon-Like Peptide 1 (GLP-1)
The General Hospital Corporation
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 10159714-B22018-12-25
Compositions, devices and methods of use thereof for the treatment of cancers
Intarcia Therapeutics, Inc.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
EP 3417871-A12018-12-26
PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1-AGONIST, AN INSULIN, AND METHIONINE
SANOFI AVENTIS DEUTSCHLAND
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 10189884-B22019-01-29
Thioamide-modified peptides and uses thereof
The Trustees of the University of Pennsylvania and President and Fellows of Harvard College
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10189884-B22019-01-29
- US 11891425-B22024-02-06
-
EP 3456340-A12019-03-20
GLP-1 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF CONGENITAL HYPERINSULINISM
UNIV PENNSYLVANIA
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 10286037-B22019-05-14
Methods of producing lyophilized polypeptide composition formulations comprising volatile additives
GlaxoSmithKline LLC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 10286078-B22019-05-14
Modified therapeutic agents and compositions thereof
THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH and THE SCRIPPS RESEARCH INSTITUTE
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 10301268-B22019-05-28
Analogs of fexaramine and methods of making and using
The Salk Institute for Biological Studies and University of Sydney
Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10301268-B22019-05-28
- US 10450277-B22019-10-22
-
US 10363287-B22019-07-30
Method of manufacturing an osmotic delivery device
INTARCIA THERAPEUTICS, INC.
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 10408813-B22019-09-10
Biosensor for detecting intracellular cyclic adenosine monophosphate (cAMP) and uses thereof
Academia Sinica
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
US 10420844-B22019-09-24
Peptide pharmaceuticals
Mederis Diabetes LLC
Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
-
WO 2019197466-A12019-10-17
METHOD FOR CLEAVAGE OF SOLID PHASE-BOUND PEPTIDES FROM THE SOLID PHASE
SANOFI AVENTIS DEUTSCHLAND
Query Match 96.3%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019197466-A12019-10-17
- KR 1020200142033-A2020-12-21
- JP 2021521156-A2021-08-26
- US 11560402-B22023-01-24
-
WO 2019197469-A12019-10-17
LIXISENATIDE SYNTHESIS WITH CAPPING
SANOFI AVENTIS DEUTSCHLAND
Query Match 96.3%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30 |||||||||||||||||||||||||||||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 3030 of 30 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019197469-A12019-10-17
- KR 1020200142032-A2020-12-21
- JP 2021521144-A2021-08-26